---
title: "Imbruvica (ibrutinib), all indications: Storage and supply questions"
description: "Storage and supply questions on Imbruvica (ibrutinib) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied, Packaging, and Storage. Questions: What forms and strengths does Imbruvica come in? How is Imbruvica packaged? How should Imbruvica be stored? How long can Imbruvica oral suspension be used after opening? 4 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/imbruvica/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Imbruvica (ibrutinib), all indications: Storage and supply questions

Manufacturer: Pharmacyclics LLC; Janssen Biotech, Inc.  
Prescribing information: [Imbruvica](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf)  
Indication pages: [Chronic lymphocytic leukemia and small lymphocytic lymphoma](https://www.evicenter.com/medical-information/imbruvica--chronic-lymphocytic-leukemia-and-small-lymphocytic-lymphoma)

## How supplied

<a id="imbruvica-formulations"></a>

### What forms and strengths does Imbruvica come in?

> “Capsules: 
> Each 70 mg capsule is a yellow, opaque capsule marked with “ibr 70 mg” in black ink. 
> Each 140 mg capsule is a white, opaque capsule marked with “ibr 140 mg” in black ink. 
> Tablets: 
> Each 140 mg tablet is a yellow green to green round tablet debossed with “ibr” on one side and 
> “140” on the other side. 
> Each 280 mg tablet is a purple oblong tablet debossed with “ibr” on one side and “280” on the 
> other side. 
> Each 420 mg tablet is a yellow green to green oblong tablet debossed with “ibr” on one side and 
> “420” on the other side.  
> Oral Suspension: 
> 70 mg/mL, white to off-white suspension.”

Source: [IMBRUVICA: Prescribing information, page 7, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=7)

## Packaging

<a id="imbruvica-packaging"></a>

### How is Imbruvica packaged?

> “IMBRUVICA<sup>®</sup> capsules are supplied in white HDPE bottles with a child-resistant closure. Capsules are supplied in 2 dosage strengths:
>
> Yellow opaque capsules marked with “ibr 70 mg” in black ink
> White opaque capsules marked with “ibr 140 mg” in black ink
>
> IMBRUVICA<sup>®</sup> tablets are available in a carton of one folded blister card containing two 14-count blister strips for a total of 28 tablets. Tablets are supplied in 4 dosage strengths:
>
> Yellow-green to green round tablets debossed with “ibr" on one side and "140” on the other side
> Purple oblong tablets debossed with “ibr” on one side and "280" on the other side
> Yellow-green to green oblong tablets debossed with “ibr” on one side and "420" on the other side
>
> IMBRUVICA<sup>®</sup> oral suspension is a white to off-white suspension supplied as 108 mL in a 150 mL amber glass bottle with a pre-inserted bottle adapter and a child-resistant closure. Each mL contains 70 mg of IMBRUVICA<sup>®</sup>. The oral suspension bottle is provided in a carton with two 3 mL reusable oral dosing syringes.”

Source: [IMBRUVICA: NDC Numbers - CLL/SLL, captured 2026-11-13](https://www.imbruvicahcp.com/cll/support-and-resources/ndc-codes#:~:text=capsules%20are%20supplied%20in%20white,mL%20reusable%20oral%20dosing%20syringes.)

## Storage

<a id="imbruvica-storage"></a>

### How should Imbruvica be stored?

> “Store IMBRUVICA<sup>®</sup> capsules and tablets in its original packaging at room temperature, 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F to 86°F).
>
> Store the oral suspension bottle at 2°C to 25°C (36°F to 77°F). Do not freeze. Dispense in original sealed container. Do not use if the carton seal is broken or missing.”

Source: [IMBRUVICA: NDC Numbers - CLL/SLL, captured 2026-11-13](https://www.imbruvicahcp.com/cll/support-and-resources/ndc-codes#:~:text=Store,seal%20is%20broken%20or%20missing.)

<a id="imbruvica-oral-suspension-after-opening"></a>

### How long can Imbruvica oral suspension be used after opening?

> “Discard any unused IMBRUVICA oral suspension remaining 60 days after first opening the 
> bottle.”

Source: [IMBRUVICA: Prescribing information, page 53, captured 2026-11-13](https://www.rxabbvie.com/pdf/imbruvica_pi.pdf#page=53)

## Related pages
- [Medical information: Imbruvica (ibrutinib): All indications](https://www.evicenter.com/medical-information/imbruvica)
- [Indication](https://www.evicenter.com/medical-information/imbruvica/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/imbruvica/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/imbruvica/safety)
- [Specific populations](https://www.evicenter.com/medical-information/imbruvica/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/imbruvica/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/imbruvica/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/imbruvica/access-and-coverage)
